Related Experiment Video
Updated: Jul 3, 2026

06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy
Andrew Z Wang1, Vaishali Bagalkot, Christophoros C Vasilliou
1Laboratory of Nanomedicine and Biomaterials, Department of Anesthesia, Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.
Chemmedchem
|July 10, 2008
Abstract
No abstract available in PubMed .

